Inhibition of forkhead box O1 protects pancreatic β-cells against dexamethasone-induced dysfunction

Endocrinology

Volumn 150, Issue 9, 2009, Pages 4065-4073

  Zhang, Xiongfei ^a,b   Yong, Wei ^a   Lv, Jinghuan ^a   Zhu, Yunxia ^a   Zhang, Jingjing ^a   Chen, Fang ^a   Zhang, Rihua ^a   Yang, Tao ^a   Sun, Yujie ^a   Han, Xiao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTOR; GLUCOSE; INSULIN; MESSENGER RNA; PROTEIN FORKHEAD BOX O1; PROTEIN KINASE B BETA; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INSULIN RELEASE; NONHUMAN; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CELL NUCLEUS; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TRANS-ACTIVATORS;

EID: 69249139619     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0343     Document Type: Article

References (50)

1. Hoogwerf B, Danese RD 1999 Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin North Am 25:489-505
2. Schäcke H, Döcke WD, Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43
3. Tounian P, Schneiter P, Henry S, Delarue J, Tappy L 1997 Effects of dexamethasone on hepatic glucose production and fructose metabolism in healthy humans. Am J Physiol 273:E315-E320
4. Wang JC, Stafford JM, Scott DK, Sutherland C, Granner DK 2000 The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J Biol Chem 275:14717-14721
5. Burén J, Liu HX, Jensen J, Eriksson JW 2002 Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol 146:419-429
6. Ruzzin J, Wagman AS, Jensen J 2005 Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48:2119-2130
7. Gesina E, Tronche F, Herrera P, Duchene B, Tales W, Czernichow P, Breant B 2004 Dissecting the role of glucocorticoids on pancreas development. Diabetes 53:2322-2329
8. Lambillotte C, Gilon P, Henquin JC 1997 Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99:414-423
9. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426
10. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-1847
11. Martinez SC, Tanabe K, Cras-Méneur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA 2008 Inhibition of Foxo1 protects pancreatic islet β-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57:846-859
12. Nakae J, Biggs 3rd WH, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D 2002 Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245-253
13. Barthel A, Schmoll D, Krüger KD, Bahrenberg G, Walther R, Roth RA, Joost HG 2001 Differential regulation of endogenous glucose-6- phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun 285:897-902
14. Kwon HS, Huang B, Unterman TG, Harris RA 2004 Protein kinase B-α inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 53:899-910
15. Han X, Sun Y, Scott S, Bleich D 2001 Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and β-cells. Diabetes 50:1047-1055
16. Shen C, Buck AK, Liu X, Winkler M, Reske SN 2003 Gene silencing by adenovirus-delivered siRNA. FEBS Lett 539:111-114
17. Zhang HJ, Walseth TF, Robertson RP 1989 Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes 38:44-48
18. Imae M, Fu Z, Yoshida A, Noguchi T, Kato H 2003 Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J Mol Endocrinol 30:253-262
19. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P 1999 Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274:17179-17183
20. Biggs III WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC 1999 Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96:7421-7426
21. Chrysis D, Zaman F, Chagin AS, Takigawa M, Sävendahl L 2005 Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′-kinase signaling pathway. Endocrinology 146:1391-1397
22. Wang X, Hu J, Price SR 2007 Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells. Am J Physiol Cell Physiol 292:C1874-C1879
23. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
24. Martinez SC, Cras-Méneur C, Bernal-Mizrachi E, Permutt MA 2006 Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet β-cell. Diabetes 55:1581-1591
25. Edlund H 2001 Developmental biology of the pancreas. Diabetes 50(Suppl 1):S5-S9
26. Kushner JA, Ye J, Schubert M, Burks DJ, Dow MA, Flint CL, Dutta S, Wright CV, Montminy MR, White MF 2002 Pdx1 restores β cell function in Irs2 knockout mice. J Clin Invest 109:1193-1201
27. Lebrun P, Montminy MR, Van Obberghen E 2005 Regulation of the pancreatic duodenal homeobox-1 protein by DNA-dependent protein kinase. J Biol Chem 280:38203-38210
28. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP 1999 Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96:10857-10862
29. Olson LK, Qian J, Poitout V 1998 Glucose rapidly and reversibly decreases INS-1 cell insulin gene transcription via decrements in STF-1 and C1 activator transcription factor activity. Mol Endocrinol 12:207-219
30. Shinozuka Y, Okada M, Oki T, Sagane K, Mizui Y, Tanaka I, Katayama K, Murakami-Murofushi K 2001 Altered expression of HES-1, BETA2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells. Biochem Biophys Res Commun 287:229-235
31. Shen CN, Seckl JR, Slack JM, Tosh D 2003 Glucocorticoids suppress β-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 375:41-50
32. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y 2006 The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281:1091-1098
33. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D, Dong H 2003 Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 285:E718-E728
34. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM 2003 Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature 423:550-555
35. Matsumoto M, Accili D 2006 The tangled path to glucose production. Nat Med 12:33-34; discussion 34
36. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M, Unterman TG 2006 FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281:10105-10117
37. Nakae J, Kitamura T, Kitamura Y, Biggs 3rd WH, Arden KC, Accili D 2003 The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119-129
38. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O 2004 Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279:41114-41123
39. Samuel VT, Choi CS, Phillips TG, Romanelli AJ, Geisler JG, Bhanot S, McKay R, Monia B, Shutter JR, Lindberg RA, Shulman GI, Veniant MM 2006 Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55:2042-2050
40. Hennige AM, Ozcan U, Okada T, Jhala US, Schubert M, White MF, Kulkarni RN 2005 Alterations in growth and apoptosis of insulin receptor substrate-1-deficient β-cells. Am J Physiol Endocrinol Metab 289:E337-E346
41. Buteau J, Shlien A, Foisy S, Accili D 2007 Metabolic diapause in pancreatic β-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 282:287-293
42. Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, Accili D 2005 FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab 2:153-163
43. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC 2002 Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225-11232
44. Rafiq I, Kennedy HJ, Rutter GA 1998 Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 β-cells. J Biol Chem 273:23241-23247
45. Rafiq I, da Silva Xavier G, Hooper S, Rutter GA 2000 Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem 275:15977-15984
46. Vogt PK, Jiang H, Aoki M 2005 Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4:908-913
47. Davani B, Khan A, Hult M, Mårtensson E, Okret S, Efendic S, Jö rnvall H, Oppermann UC 2000 Type 1 11β-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J Biol Chem 275:34841-34844
48. Stewart PM 1996 11β-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol (Oxf) 44:493-499
49. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
50. Swali A, Walker EA, Lavery GG, Tomlinson JW, Stewart PM 2008 11β-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Diabetologia 51:2003-2011